Diligent Robotics
AcquiredAustin, US · 171 employees on LinkedIn · 15 known investors
Find your way into Diligent Robotics
485 people in our graph share verified history with the Diligent Robotics team — schools, employers, funds. One of them is your warm intro.
Diligent Robotics develops AI-powered robot assistants for healthcare settings, focusing on mobile manipulation and social intelligence to help hospital staff with routine non-patient-facing tasks. The company's flagship product, Moxi, enables clinical staff to dedicate more time to direct patient care.
Also known as Diligent · Diligent Robotics, Inc.
Founders & leadership


Board
Investors · 15
Also in the syndicate · 2
Reported raises · per SEC filings
Form D private placements$54.8M disclosed across 2 of 4 rounds · 2022–2025
▶$10.5MraisedFeb 2025 · 3 investors · Other TechnologyRule 506(b)
- Rohit SharmaDirector
- Lance VandenBrookDirector
- Quaeed MotiwalaDirector
- Andrea ThomazExecutive Officer, Director
- Richard BoyleDirector
- Vivian ChuDirector
- Offering amount
- $20M
- Amount sold
- $10.5M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$44.3MraisedOct 2024 · 31 investors · Other TechnologyRule 506(b)
- Quaeed MotiwalaDirector
- Lance VandenBrookDirector
- Richard BoyleDirector
- Andrea ThomazExecutive Officer, Director, Promoter
- Vivian ChuExecutive Officer, Director, Promoter
- Rohit SharmaDirector
- Offering amount
- $52.1M
- Amount sold
- $44.3M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Diligent Robotics is an artificial intelligence and robotics company based in Austin, Texas, that develops socially intelligent service robots for healthcare environments. Its flagship product, Moxi, is a mobile robot with an arm and gripper that assists clinical staff with non-patient-facing tasks such as fetching and delivering supplies from central supply, running patient supplies, delivering medications and lab samples, distributing PPE, moving telemetry boxes and transferring light-weight equipment between units. Moxi is positioned as a support for the whole care team and is also used within clinical programs such as Meds-to-Beds and in centralized telemetry and supply chain operations.
The company describes three core technical capabilities: social intelligence (autonomously calling elevators and opening doors, navigating hallways around people, interacting with patients and staff), mobile manipulation (grabbing, pulling, opening and guiding objects without human assistance), and human-guided learning, through which Moxi adapts to a given hospital's workflows as staff use it. Deployment is designed to avoid infrastructure buildout, relying on a hospital's existing Wi-Fi, with Diligent's implementation team configuring operational workflows; the company states implementations can move from pilot to production in roughly 12 weeks. Diligent frames the market opportunity around nurse burnout and staffing shortages, citing that nurses spend up to 30% of their time on non-value-added tasks and a bedside nurse turnover rate of 16.8%.
In January 2026, Serve Robotics, a publicly traded sidewalk delivery robot company, announced its acquisition of Diligent Robotics, valuing Diligent's common stock at $29 million. Serve said Diligent would continue to operate relatively independently while sharing technology and tapping Serve's software and tools to support scaling.
Founding story
The company was founded in 2017 by two women social robotics experts, Andrea Thomaz (CEO and co-founder) and Vivian Chu (Chief Innovation Officer and co-founder), to build robots with mobile manipulation, social intelligence and human-guided learning capabilities. The founders were trained as roboticists at MIT and Georgia Tech, and the company's technology was shaped by years of research at the University of Texas at Austin.
Business model
Diligent sells robot-based automation to hospitals and health systems, pairing the Moxi robot with software workflows and an implementation team that configures and expands the tasks the robot performs. The company positions itself as venture-backed and commercially deployed, working with clinical and operations experts at customer sites to streamline processes, reduce costs and open new revenue opportunities such as centralized telemetry and supply chain services.
Public materials indicate Diligent provides Moxi robots as fleets deployed inside hospitals, with implementation services and software that lets customers add new workflows over time; customers have expanded fleets after initial trials. Specific pricing or contract structures are not disclosed in available sources.
Traction
Company materials cite more than 9,900 labs delivered at UTMB Angleton Danbury, more than 595 days' worth of time returned to nurses at Mary Washington Healthcare, and 6,350 hours saved for the pharmacy department at Shannon Health. Fleets operate 24/7 at customer sites, and Mary Washington Healthcare added additional robots after an initial trial that began in December. As of April 2022, Moxi was deployed and integrated across a range of health systems nationally following first commercial deployments in 2020, and the company reported skyrocketing demand and rapid team expansion. Total venture capital raised exceeded $75 million as of January 2026.
Latest developments
In January 2026, Serve Robotics announced the acquisition of Diligent Robotics, in a deal valuing Diligent's common stock at $29 million. Serve's CEO Ali Kashani said Diligent had been looking to scale while Serve was exploring new areas, that Diligent would continue to operate relatively independently within Serve, and that the two companies would share technology with Diligent using Serve's software and tools.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Diligent describes itself as a pioneer in human-robot interaction and, as of 2022, as the leading company in the social robotics space and the first to combine social intelligence with mobile manipulation in a workplace robot. The company frames its addressable market using a Research and Markets estimate that the global smart hospital market was $27.6 billion in 2021 and would reach $82.89 billion by 2026, a 24.6% compound annual growth rate. Third-party commentary from ZDNET characterized Moxi as a socially intelligent robot able to aid nurses without making people uncomfortable.
Diligent positions Moxi as more than an automated delivery cart: a robot teammate that is dexterous (compliant arm and hand), autonomous end-to-end, proactive in anticipating staff needs, and socially intelligent enough to operate among people and interact with patients and staff. It emphasizes being first to combine social intelligence with mobile manipulation in a workplace robot, rapid implementation without facility infrastructure changes, and human-guided learning that lets the robot adapt to each hospital's practices.
Technology
Moxi combines autonomous navigation in semi-structured hospital environments with a compliant arm and hand for manipulation, allowing it to grab, pull, open and guide objects unaided. Social intelligence features let it call elevators and open doors on its own and avoid people and obstacles in hallways, and it uses expressive interactions such as waving and displaying heart eyes. Human-guided learning enables the robot to adapt to a hospital's environment and workflows through staff use, and workflow software allows new tasks to be added dynamically. Deployment requires no infrastructure buildout and runs over a hospital's existing Wi-Fi. Amazon Web Services is listed among the company's technology partners.
Go-to-market
The company markets directly to hospitals and health systems, with demo bookings as the primary funnel entry point and customer-facing content built around quantified time savings and clinical staff testimonials from chief nursing officers, innovation managers and administrators. Sales are supported by a dedicated implementation team that customizes operational workflows during setup. Diligent also expanded operations, sales and engineering to meet demand after 2022, and its work with the Cedars-Sinai Accelerator provided a route into clinical testing at that health system. Amazon Web Services is identified as a technology partner.
Hospitals and health systems in the United States, including multi-location systems, community hospitals and academic medical centers. Within those organizations, buyers and users include chief nursing officers, nursing and clinical staff, pharmacy departments, radiology staff, supply chain and innovation/performance-improvement leaders.
Geography
Diligent is headquartered in Austin, Texas, and describes deployments at health systems across the United States, ranging from multi-location systems to smaller community hospitals and large academic and research-focused systems. Named sites and customers include UTMB Health Angleton Danbury, Mary Washington Healthcare, Shannon Medical Center/Shannon Health, Endeavor Health (including Edward Hospital), Medical City Denton, Novant Health and Cedars-Sinai in Los Angeles. Early research trials between 2018 and 2019 involved four health systems in Texas. Acquirer Serve Robotics is based in Los Angeles.
History
Diligent Robotics was founded in 2017 by social robotics researchers, with roots in research conducted at the University of Texas at Austin and founders trained at MIT and Georgia Tech. The company debuted Moxi in 2018. Between 2018 and 2019 it partnered with four Texas health systems on a series of research trials, using the findings to shape how Moxi fits into clinical workflows, and began first commercial deployments in 2020. The company participated in the Cedars-Sinai Accelerator program, which led to testing with Cedars-Sinai clinical teams. It raised a Series A round (approximately two years before April 2022), over $30 million in Series B funding in April 2022 led by Tiger Global, and, according to press coverage, a $25 million round in 2023, bringing total venture capital raised to more than $75 million. In January 2026, Serve Robotics announced its acquisition of the company.
Risks & controversies
The company's disclosed context includes dependence on hospital labor-shortage economics as the driver of demand, hardware supply chain and deployment scaling constraints (an explicit use of Series B proceeds), and the need for interoperability with existing hospital infrastructure, electronic health records and clinical communications systems. Following the January 2026 acquisition announcement by Serve Robotics, Diligent's independence as a standalone company ends, though Serve stated it would continue to operate relatively independently.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 3
by search overlapCompanies competing with Diligent Robotics for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 6
launches, deals, and filingsServe Robotics, a publicly traded sidewalk delivery robot company backed by Nvidia and Uber, announced it was acquiring Diligent Robotics in a deal valuing Diligent's common stock at $29 million. It is Serve's first expansion beyond food delivery; Diligent is to operate relatively independently while sharing technology and using Serve's software and tools.
$29M source ↗
Press coverage of the 2026 acquisition noted Diligent's most recent prior raise was a $25 million funding round in 2023.
$25M source ↗
Diligent closed over $30 million in Series B funding led by Tiger Global, with participation from existing investors True Ventures, DNX Venture, Ubiquity Ventures, E14 Fund, Next Coast Ventures, Boom Capital and Gaingels, plus new investor Cedars-Sinai Health Ventures. Total raised to date reached nearly $50 million. Proceeds were earmarked for supply chain and design optimization, faster robot deployment, and interoperability with hospital infrastructure, EHRs and clinical communications.
$30M source ↗
Diligent's participation in the Cedars-Sinai Accelerator program led to testing Moxi with Cedars-Sinai clinical teams, with Cedars-Sinai's chief nursing executive describing a successful original launch relieving front-line workers of point-to-point delivery and retrieval tasks.
After research trials with four Texas health systems between 2018 and 2019, Diligent began its first commercial deployments of Moxi in 2020.
Diligent Robotics debuted Moxi, a collaborative robot assistant that helps clinical staff with routine non-patient-facing tasks such as fetching and delivering supplies, medications and lab samples.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- Diligent Roboticsdiligentrobots.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Diligent Robotics do?
- Diligent Robotics builds Moxi, an AI-powered mobile manipulation robot that runs deliveries and routine tasks for hospital staff.
- Who founded Diligent Robotics?
- Diligent Robotics was founded by Andrea L. Thomaz, Vivian Chu.
- Who are Diligent Robotics's investors?
- Diligent Robotics's investors include ATP, Canaan Partners, Correlation Ventures, Dnx Ventures, Grit Ventures, Next Coast Ventures, Pathbreaker Ventures, Plum Alley Investments and 5 more.
- How much funding has Diligent Robotics raised?
- Diligent Robotics has disclosed $54.8M raised across 2 of its 4 known rounds.
- Where is Diligent Robotics headquartered?
- Diligent Robotics is headquartered in Austin, US.








